F Taieb - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F Taieb

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Medecine Et Maladies Infectieuses|June 18, 2010

[Epidemiology of patients harboring extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), on admission]M Guillet, E Bille, H Lecuyer, et al.

Medecine Et Maladies Infectieuses|December 4, 2009

[Optimized clinical use of vancomycin, a prospective observational study in a Paris teaching hospital]F Taieb, A Le Monnier, E Bille, et al.

Investigational New Drugs|October 26, 2014

Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patientsC Narjoz, A Cessot, A Thomas-Schoemann, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Medecine Et Maladies Infectieuses|June 18, 2010

[Epidemiology of patients harboring extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), on admission]M Guillet, E Bille, H Lecuyer, et al.

Medecine Et Maladies Infectieuses|December 4, 2009

[Optimized clinical use of vancomycin, a prospective observational study in a Paris teaching hospital]F Taieb, A Le Monnier, E Bille, et al.

Investigational New Drugs|October 26, 2014

Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patientsC Narjoz, A Cessot, A Thomas-Schoemann, et al.

Pageof 2